SCHEMBL9856887

SCHEMBL9856887

CNCCC(Cc1cccc(C)c1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 4/20 0.49
HRH1 P35367 4/20 0.49
SLC6A4 P31645 8/20 0.45
SLC6A2 P23975 5/20 0.45
CTSL P07711 1/20 0.42
CTSB P07858 1/20 0.42
CTSS P25774 1/20 0.42
CYP3A4 P08684 4/20 0.40
CYP2D6 P10635 4/20 0.40
CYP1A2 P05177 3/20 0.40
SLC6A3 Q01959 3/20 0.40
KCNH2 Q12809 3/20 0.40
CHRM1 P11229 2/20 0.40
TSHR P16473 2/20 0.40
ADRA2B P18089 2/20 0.40
HTR2C P28335 2/20 0.40
OPRM1 P35372 2/20 0.40
DRD3 P35462 2/20 0.40
OPRK1 P41145 2/20 0.40
HTR2B P41595 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL9856450 0.90 NOS2 (0.45) HTR2AHRH1SLC6A4SLC6A2CTSL
Fumaric Acid SCHEMBL9856436 0.90 NOS2 (0.45) HTR2AHRH1SLC6A4SLC6A2CTSL
Fumaric Acid SCHEMBL9856447 0.90 NOS2 (0.45) HTR2AHRH1SLC6A4SLC6A2CTSL
SCHEMBL8384207 0.86 HTR2A (0.60) HTR2AHRH1SLC6A4SLC6A2CYP3A4
SCHEMBL9857077 0.85 HTR2A (0.49) HTR2AHRH1SLC6A4SLC6A2CYP3A4
SCHEMBL9857036 0.85 HTR2A (0.49) HTR2AHRH1SLC6A4SLC6A2CTSB
SCHEMBL9856737 0.84 SLC6A4 (0.54) HTR2AHRH1SLC6A4SLC6A2KMT2A
SCHEMBL9856768 0.84 TAAR1 (0.54) HTR2AHRH1SLC6A4SLC6A2CYP3A4
SCHEMBL9857294 0.83 HTR2A (0.53) HTR2AHRH1SLC6A4SLC6A2CYP3A4
SCHEMBL6547355 0.83 ESR1 (0.46) HTR2AHRH1SLC6A4SLC6A2CTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4996235-A Selectively inhibiting the uptake of serotonin and norepinephrine ELI LILLY AND COMPANY (US) 1991-02-26 US disclosed
EP-0318233-A2 Improvements in or relating to serotonin and norepinephrine uptake inhibitors ELI LILLY AND COMPANY (US) 1989-05-31 EP disclosed